Charles River Laboratories has a total of 512 patents globally, out of which 238 have been granted. Of these 512 patents, more than 42% patents are active. United States Of America is where Charles River Laboratories has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Charles River Laboratories.
Charles River Laboratories was founded in 1947 by Henry Foster. Charles River Laboratories, Inc. provides clinical tests and drug development services. The Company offers test and development services for vaccines, biosimilars, and medicine to treat cardiovascular, skeletal, endocrine, central nervous system, cancer, and other sorts of ailments. Charles River Laboratories provides their services globally.As of April 2022 Charles River Laboratories has a market cap of $14.76 Billion.
Do read about some of the most popular patents of Charles River Laboratories which have been covered by us in this article and also you can find Charles River Laboratories patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Charles River Laboratories patent portfolio.
How many patents does the Founder and CEO of Charles River Laboratories have?
The Founder & CEO, Henry Foster and James C. Foster has 0 patents.
How many patents does Charles River Laboratories have?
Charles River Laboratories has a total of 512 patents globally. These patents belong to 141 unique patent families. Out of 512 patents, 218 patents are active.
How Many Patents did Charles River Laboratories File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Charles River Laboratories Applications Filed | Charles River Laboratories Patents Granted |
2010 | 16 | 3 |
2011 | 46 | 8 |
2012 | 4 | 16 |
2013 | 56 | 6 |
2014 | 74 | 24 |
2015 | 21 | 30 |
2016 | 17 | 21 |
2017 | 25 | 16 |
2018 | 8 | 23 |
2019 | 6 | 12 |
2020 | 16 | 4 |
2021 | 5 | 12 |
2022 | – | 2 |
How many Charles River Laboratories patents are Alive/Dead?
Worldwide Patents
How Many Patents did Charles River Laboratories File in Different Countries?
Countries in which Charles River Laboratories Filed Patents
Country | Patents |
United States Of America | 1250 |
Europe | 683 |
Germany | 383 |
China | 362 |
Japan | 351 |
Canada | 291 |
Australia | 195 |
India | 54 |
Singapore | 43 |
Hong Kong (S.A.R.) | 43 |
Spain | 40 |
France | 37 |
Austria | 34 |
Korea (South) | 23 |
Brazil | 18 |
Russia | 12 |
Denmark | 12 |
Mexico | 11 |
New Zealand | 8 |
United Kingdom | 7 |
Israel | 7 |
Portugal | 6 |
Poland | 4 |
South Africa | 2 |
Taiwan | 1 |
Netherlands | 1 |
Argentina | 1 |
Norway | 1 |
Czech Republic | 1 |
Hungary | 1 |
Where are Research Centers of Charles River Laboratories Patents Located?
10 Best Charles River Laboratories Patents
US6429013B1 is the most popular patent in the Charles River Laboratories portfolio. It has received 325 citations so far from companies like Imaging Therapeutics and Medtronic Vascular.
Below is the list of 10 most cited patents of Charles River Laboratories:
Publication Number | Citation Count |
US6429013B1 | 325 |
US6555374B1 | 278 |
US6391297B1 | 201 |
US20120019559A1 | 195 |
WO2015069770A1 | 143 |
US6841150B2 | 139 |
US7078232B2 | 119 |
US7033587B2 | 68 |
US20150202291A1 | 55 |
USD472324S1 | 54 |
What Percentage of Charles River Laboratories US Patent Applications were Granted?
Charles River Laboratories (Excluding its subsidiaries) has filed 70 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 42 have been granted leading to a grant rate of 77.78%.
Below are the key stats of Charles River Laboratories patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Charles River Laboratories?
Law Firm | Total Applications | Success Rate |
Goodwin Procter | 30 | 64.29% |
Wilson Sonsini Goodrich & Rosati | 15 | 100.00% |
Dechert | 6 | 100.00% |
Sterne Kessler Goldstein & Fox | 4 | 100.00% |
Element Ip | 2 | 0% |
Lathrop Gpm | 2 | 0% |
Choate Shire | 1 | 100.00% |
Cooley | 1 | 100.00% |
Foley Hoag | 1 | 0% |
Genzyme | 1 | 100.00% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Charles River Laboratories’ key innovation segments?